In addition, it was found that proteins related to cell proliferation like CDK-4, CDK-6 and Cyclin D1, were also decreased in the flimsy Bacteroides treatment group (p < 0.01), further enhancing its ability to inhibit the proliferation of NSCLC cells. The gene discussed is CDK6; the disease is non-small cell lung carcinoma.